KNBIF

Kane Biotech Inc. KNBIF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode KNBIF NTII PHGUF HESG MMIRF OCTHF
6M -53.14 % 0.00 % 66.67 % 0.00 % 141.55 % 0.00 %
YTD -57.40 % 0.00 % 52.75 % 0.00 % 281.68 % 0.00 %
1Y -66.45 % 0.00 % 75.23 % 0.00 % 0.00 % 0.00 %
3Y -56.27 % 0.00 % 44.93 % -90.00 % -19.35 % -81.33 %
5Y -72.67 % -97.50 % 40.19 % -90.00 % -76.52 % -94.40 %
10Y -73.76 % -99.60 % 328.57 % -90.00 % 47.06 % -94.40 %
From the beginning -98.29 % -100.00 % 167.86 % -100.00 % -9.42 % -94.40 %

Dividend

Neurobiological Technologies, Inc.